US 9,060,992 B2
Treatment of short bowel syndrome patients with colon-in-continuityGeneral
US 9,060,992 B2
Treatment of short bowel syndrome patients with colon-in-continuity
Tech Center:
1600
Examiner:
Satyanarayana R Gudibande
Art Unit:
1676
Agent:
Inventors:
Elizabeth Lemaire Sanguinetti; Thomas B. Marriott; Jennifer Lopansri; Consuelo Maria Blosch
Assignee:
Priority:
11/01/04
Filed:
11/02/10
Granted:
06/23/15
Expiration:
08/30/27
Abstract
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
Cooperative Patent Classification (CPC)
A61A61P1/02A61K9/0019A61B5/4222A61P